Elekta AB (publ) (EKTAF)
USD 5.0
(0.0%)
USD 5.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 5.75 Billion SEK | 25.69% |
| 2023 | 5.39 Billion SEK | 19.85% |
| 2022 | 4.49 Billion SEK | -0.04% |
| 2021 | 4.5 Billion SEK | -9.24% |
| 2020 | 4.95 Billion SEK | 3.68% |
| 2019 | 4.78 Billion SEK | 7.9% |
| 2018 | 4.43 Billion SEK | 16.29% |
| 2017 | 3.81 Billion SEK | -5.81% |
| 2016 | 4.04 Billion SEK | -6.01% |
| 2015 | 4.3 Billion SEK | -7.34% |
| 2014 | 4.64 Billion SEK | -2.82% |
| 2013 | 4.78 Billion SEK | 13.4% |
| 2012 | 4.21 Billion SEK | 15.0% |
| 2011 | 3.66 Billion SEK | 7.66% |
| 2010 | 3.4 Billion SEK | 12.37% |
| 2009 | 3.03 Billion SEK | 38.91% |
| 2008 | 2.18 Billion SEK | 16.25% |
| 2007 | 1.87 Billion SEK | -1.31% |
| 2006 | 1.9 Billion SEK | 52.16% |
| 2005 | 1.25 Billion SEK | 11.91% |
| 2004 | 1.11 Billion SEK | 9.19% |
| 2003 | 1.02 Billion SEK | -1.63% |
| 2002 | 1.04 Billion SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q4 | 1.82 Billion SEK | 9.98% |
| 2024 Q1 | 1.59 Billion SEK | -17.66% |
| 2024 FY | 5.75 Billion SEK | 6.68% |
| 2024 Q2 | 1.69 Billion SEK | 6.6% |
| 2024 Q3 | 1.66 Billion SEK | -1.89% |
| 2023 Q2 | 1.47 Billion SEK | 14.83% |
| 2023 Q3 | 1.72 Billion SEK | 16.9% |
| 2023 Q4 | 1.93 Billion SEK | 11.68% |
| 2023 FY | 5.39 Billion SEK | 19.85% |
| 2023 Q1 | 1.28 Billion SEK | -17.96% |
| 2022 Q3 | 1.32 Billion SEK | -7.29% |
| 2022 Q4 | 1.57 Billion SEK | 18.67% |
| 2022 FY | 4.49 Billion SEK | -0.04% |
| 2022 Q1 | 1.11 Billion SEK | -20.98% |
| 2022 Q2 | 1.42 Billion SEK | 27.98% |
| 2021 FY | 4.5 Billion SEK | -9.24% |
| 2021 Q4 | 1.41 Billion SEK | 1.73% |
| 2021 Q1 | 1.36 Billion SEK | -19.92% |
| 2021 Q2 | 1.44 Billion SEK | 5.71% |
| 2021 Q3 | 1.38 Billion SEK | -4.01% |
| 2020 Q2 | 1.52 Billion SEK | 10.62% |
| 2020 Q3 | 1.53 Billion SEK | 0.92% |
| 2020 Q4 | 1.7 Billion SEK | 11.21% |
| 2020 FY | 4.95 Billion SEK | 3.68% |
| 2020 Q1 | 1.37 Billion SEK | -25.55% |
| 2019 Q4 | 1.84 Billion SEK | 36.51% |
| 2019 Q3 | 1.35 Billion SEK | -1.74% |
| 2019 Q1 | 1.1 Billion SEK | -26.17% |
| 2019 Q2 | 1.37 Billion SEK | 24.84% |
| 2019 FY | 4.78 Billion SEK | 7.9% |
| 2018 Q2 | 1.25 Billion SEK | 8.44% |
| 2018 Q4 | 1.49 Billion SEK | 25.02% |
| 2018 FY | 4.43 Billion SEK | 16.29% |
| 2018 Q1 | 1.16 Billion SEK | -26.33% |
| 2018 Q3 | 1.19 Billion SEK | -5.08% |
| 2017 Q3 | 1.06 Billion SEK | 3.61% |
| 2017 FY | 3.81 Billion SEK | -5.81% |
| 2017 Q1 | 764 Million SEK | -50.39% |
| 2017 Q4 | 1.57 Billion SEK | 48.4% |
| 2017 Q2 | 1.02 Billion SEK | 34.16% |
| 2016 FY | 4.04 Billion SEK | -6.01% |
| 2016 Q4 | 1.54 Billion SEK | 52.93% |
| 2016 Q1 | 885 Million SEK | -44.83% |
| 2016 Q3 | 1 Billion SEK | -14.73% |
| 2016 Q2 | 1.18 Billion SEK | 33.45% |
| 2015 FY | 4.3 Billion SEK | -7.34% |
| 2015 Q3 | 998 Million SEK | -6.82% |
| 2015 Q4 | 1.6 Billion SEK | 60.72% |
| 2015 Q1 | 633 Million SEK | -65.58% |
| 2015 Q2 | 1.07 Billion SEK | 69.19% |
| 2014 Q1 | 806 Million SEK | -55.17% |
| 2014 FY | 4.64 Billion SEK | -2.82% |
| 2014 Q4 | 1.83 Billion SEK | 95.64% |
| 2014 Q2 | 1.06 Billion SEK | 31.76% |
| 2014 Q3 | 940 Million SEK | -11.49% |
| 2013 Q3 | 1.08 Billion SEK | -5.64% |
| 2013 Q2 | 1.15 Billion SEK | 54.63% |
| 2013 FY | 4.78 Billion SEK | 13.4% |
| 2013 Q1 | 745 Million SEK | -50.92% |
| 2013 Q4 | 1.79 Billion SEK | 65.41% |
| 2012 Q4 | 1.51 Billion SEK | 22.32% |
| 2012 Q1 | 611 Million SEK | -50.88% |
| 2012 FY | 4.21 Billion SEK | 15.0% |
| 2012 Q2 | 847 Million SEK | 38.63% |
| 2012 Q3 | 1.24 Billion SEK | 46.52% |
| 2011 Q2 | 865 Million SEK | 19.31% |
| 2011 Q4 | 1.24 Billion SEK | 49.34% |
| 2011 Q3 | 833 Million SEK | -3.7% |
| 2011 Q1 | 725 Million SEK | -41.67% |
| 2011 FY | 3.66 Billion SEK | 7.66% |
| 2010 Q1 | 642 Million SEK | 0.0% |
| 2010 Q3 | 774 Million SEK | 3.61% |
| 2010 Q4 | 1.24 Billion SEK | 60.59% |
| 2010 Q2 | 747 Million SEK | 16.36% |
| 2010 FY | 3.4 Billion SEK | 12.37% |
| 2009 FY | 3.03 Billion SEK | 38.91% |
| 2008 FY | 2.18 Billion SEK | 16.25% |
| 2007 FY | 1.87 Billion SEK | -1.31% |
| 2006 FY | 1.9 Billion SEK | 52.16% |
| 2005 FY | 1.25 Billion SEK | 11.91% |
| 2004 FY | 1.11 Billion SEK | 9.19% |
| 2003 FY | 1.02 Billion SEK | -1.63% |
| 2002 FY | 1.04 Billion SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -338430.769% |
| Ansell Limited | 624.8 Million USD | -820.615% |
| Ansell Limited | 624.8 Million USD | -820.615% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -4948.184% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -4258905.59% |
| Psykey, Inc. | 415.97 Thousand USD | -1382672.083% |
| ConvaTec Group Plc | 1.2 Billion USD | -378.097% |
| ConvaTec Group Plc | 1.17 Billion USD | -389.615% |
| Encision Inc. | 3.13 Million USD | -183320.59% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -724321.389% |
| LifePoint, Inc. | -71.35 Thousand USD | 8060864.035% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 4390939.695% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -1095519.048% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -953417.671% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -964319.429% |
| SmileDirectClub, Inc. | 275.84 Million USD | -1985.214% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -538.594% |
| SheerVision, Inc. | 2.17 Million USD | -264249.29% |
| United Health Products, Inc. | -4857.00 USD | 118427112.559% |
| Vasamed, Inc. | -69.38 Thousand USD | 8289717.801% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -2148870.907% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -10924461.27% |